The possibility of combining potencies of non-homeopathic preparations with various nosodes (with nosodes of various diseases) has been established, their possibility in the treatment of serious diseases has been revealed. The role of highly potentiated nosodes in the treatment of serious diseases has been established.
Resonance was discovered by Galeleo Galelei in 1604 [1]. The most obvious way to describe resonance is as follows. A platoon of soldiers approaches a wooden bridge and an officer gives the order to march out of step because if the platoon of soldiers crosses the wooden bridge in step, the bridge may collapse from resonance. The vibrations of the bridge will coincide with the vibrations of the marching soldiers, a resonance will arise, from which the bridge will collapse.
The vegetative resonance test - VRT, originally proposed in 1991 by the German scientist Schimmel [2], allows for examination at one point. Testing only one biologically active point makes it possible to assess the condition of not only all organs and systems, but also their interrelations.
A computer-based bioresonance therapy device was created, which included both diagnostic and therapeutic parts. A modern bioresonance therapy device has a large selector with diagnostic (and also therapeutic) markers, information copies of diseases, which are called "nosodes" when it comes to a disease and "organopreparations" - information copies of healthy organs, when the doctor deals with normal, non-pathological organs or their parts. "Nosodes" are necessary for identifying and treating diseases and "organopreparations" for testing completely healthy organs or their parts. Nosodes are electronic markers of a disease and "organopreparations" are information markers about a healthy organ or its part, recorded on a specific carrier.
Each test drug exerts a wave effect on the patient. It is necessary to restore the patient's spectral (frequency) harmony.
Original test preparations (as opposed to their information copies) are material objects, i.e. specific substances with an atomic-molecular structure characteristic of each of them.
The program of the device for bioresonance diagnostics and therapy contains all human chromosomes, as well as the sum of all human chromosomes, which is designated as "chromosomes comp". Preliminary work was carried out using the potency of chromosomes.
During bioresonance testing, in particular, chromosomes are determined by potencies at which testing begins to manifest itself in the form of a drop of the device arrow in the middle of the screen. This potency is called "start of chromosome testing". In addition, a potency is determined at which testing stops - in this case, the arrow during testing does not give up to a certain value on the screen. This potency is called "end of chromosome testing". However, the arrow may not fall not only in the middle of the screen, but also at the end of the screen. These are important parameters of the state of chromosomes in a person, both healthy and sick, during bioresonance testing. All potencies at which various organs and organ systems, nosodes and chromosomes are tested are presented in plastic cassettes with 96 cells, each of which contains an electrode with five sugar grains in aluminum foil. It is the sugar grain that is charged and has a charge of a certain potency. Thus, each cell with an electrode is charged with a certain potency, starting from 0 to a significant value.
During bioresonance testing of diseases, the potency at which the device arrow falls in the middle of the screen is determined. This is called "test start". In addition, the potency at which testing stops is determined - while the arrow does not fall to a certain value on the screen. This potency is called "test end". All potencies at which various organs are tested are presented in plastic cassettes with 96 cells, each of which contains an electrode with five sugar grains in aluminum foil. It is the sugar grain that is charged and has a charge of a certain potency. Thus, each cell with an electrode is charged with a certain potency, starting from 0 to a significant value.
In this work, the testing of disease potencies was carried out on the IMEDIS bioresonance therapy device. The smallest potency values are located at the beginning of the plastic cassette and, as the potency value increases, they are placed sequentially in the cassette. At present, by November 2024, the author of this article has 144 cassettes from the smallest potency values to their significant values. Each cassette has its own number and cell numbers. In this work, the evaluation of potencies is reflected by the numbering (values) of the cassettes - the larger the cassette size, the greater the value of the tested potency.
The word "potency" is widely used in relation to homeopathic preparations or sexual function. In this paper we also use the word "potency", although we do not work with homeopathic preparations. The evaluation of the potency of nosodes is reflected by the numbering (size) of the cassettes - the larger the size of the cassette, the greater the value of the tested potency of the nosode. Let's briefly touch on what "drug potencies" are and how they are obtained. It has been established that the higher the potency of drugs, the higher their effectiveness.
Decimal dilutions were developed and introduced into homeopathic practice by the German physician Constantine Hering (1800-1880). Centesimal dilutions were introduced by Samuel Hahnemann, the technology of their preparation is first described in detail in the 5th edition of the Organon (1833). LM (Q) potencies, dilution of 50,000, are also Hahnemann's invention, they are described in the 6th edition of the Organon (1920). It is no coincidence that Hahnemann did not introduce high potencies of drugs - they caused an exacerbation of the course of diseases.
Without going into small details (they can be found in special reference books on the preparation of homeopathic remedies), the process of preparing liquid preparations of various potencies can be briefly described as follows. A stock solution of the active substance is taken, part of which is mixed in a certain proportion with alcohol. If the ratio is one to ten, then the first decimal dilution is obtained, designated in different countries as D or X; if one to a hundred, then the first centesimal, designated by the letter C or not designated at all.
To prepare subsequent dilutions, take the appropriate part (a tenth for decimal dilutions, a centesimal for centesimal) of the resulting solution, transfer it to a new test tube and mix it again with the appropriate amount of alcohol, as described above for preparing the first dilutions.
It has been shown that even more diluted preparations have an effect on biological objects. Thus, Professor Donders reports that one drop of atropine diluted to 1/700,000 causes pupil dilation.
In his "Insectivorous Plants", C. Darwin provides reports on experiments on the effect of weak solutions of ammonium phosphate on the plant Drosera rotundifolia. It turned out that even one fourteen-millionth part of a grain (a unit of measure of apothecary weight equal to 0.0622 gms, used before the introduction of metric measures) (1/14,000,000, i.e. the amount corresponding to the seventh decimal dilution) still exhibits a very sharp effect on the vital activity of the leaves and tentacles of this plant.
In our previous publication [1] we discussed the possibility of combining potencies of non-homeopathic medicines with potencies of chromosomes, disease nosodes. We provided isolated examples of curing diseases by increasing the potency of nosodes. To what extent is the process of connecting additional, with
The high potency of the cassettes can lead to the cure of diseases not of one patient with one disease, but of many patients with various serious diseases? In the previous work a method of converting inactive nosodes into active ones was presented. For this purpose, the principle of resonance of creation was used) [1-14].
It has been established that when new potentials are attracted using the principle of "resonance of creation", all possibilities that participate in the healing process begin to be revealed [15-18]. Thus, "active" and "inactive" chromosomes were revealed, and how "inactive" chromosomes become "active".
In other words, we added the potency found in cassette #32 to the patient's chromosome potency structure equal to cassette #3 and the end of testing to cassette #10. Let's give an example. For an 11-year-old boy, the beginning of testing was carried out using cassette #2 and the end using cassette #9, i.e. 7 cassettes were tested.
After connecting cassette #32 to the design, a change occurred. So in this case, the beginning of testing was now carried out on cassette #1, and the end on cassette #12, i.e. testing increased by 4 cassettes.
In a 50-year-old man, in the initial state, the start of testing the potency of chromosomes (sum of chromosomes) was carried out using cassette No. 18, and it ended with cassette #31, i.e. 13 cassettes were tested. After connecting a cassette with a fairly high potency (cassette #47), the testing began and took place with cassette #2, and ended with cassette #49. The testing of cassettes increased to 49 cassettes, i.e. more than 3 times.
In the initial state of an 82-year-old patient, the beginning of potency testing falls on cassette #23, and the end - on cassette #40, i.e. 17 cassettes are tested. After connecting cassette #60, i.e. strengthening the entire structure, the beginning of chromosome testing now falls on cassette #2, and the end of testing on cassette #50, i.e. 48 cassettes are tested, i.e. potency testing has increased by 3 times, as a result of which the patient develops a new quality in the treatment of diseases - the patient begins to treat those diseases that were impossible to treat before the transformations. We provide even more details in the treatment of an 82-year-old patient, which are reflected in the previous article [1].
Treatment of an 82-year-old patient with cribriform prostate cancer. 10 years ago, the patient underwent surgery to remove cribriform prostate cancer - radical prostatectomy. After 10 years, a relapse occurred, which was treated with radiotherapy. The latter is used quite widely. The patient underwent 36 procedures at 5 procedures per week. At the end of the course of radiotherapy for cribriform prostate cancer, it was found that the cancer was still being tested, i.e. the treatment was not completed. We treated this patient using resonance therapy with a changing, increasing potency of the nosode "cribriform prostate cancer". We increased the potency of the nosode in the patient to such a state that the cancer ceased to be tested, i.e. we completed the treatment of cribriform cancer Prostate gland.
The second illustration of effective treatment of cancer using the resonance therapy method with changing, increasing potency of the cancer nosode. A 52-year-old patient with lung adenocarcinoma came to us. He had this cancer operated on, but the cancer continued to be tested. We treated this cancer using the same method as the treatment of "cribriform prostate cancer" in an 82-year-old man. So, we applied the resonance therapy method with changing, increasing potency of the "lung adenocarcinoma" nosode. In our work, the potency of the cancer increased to such a state that the cancer stopped being tested. In both cases of cancer, 1.5 years have passed since the treatment, but the cancer has not relapsed. We have currently treated 14 patients with various oncological diseases, but not a single relapse has occurred.
In addition to oncological diseases, we treated five patients with multiple sclerosis with positive results. Not a single case of relapse of multiple sclerosis was detected. From the above, it is concluded that the use of the resonance therapy method with increasing potency of disease nosodes leads to the cure of these diseases.
SignUp to our
Content alerts.
Are you the author of a recent Preprint? We invite you to submit your manuscript for peer-reviewed publication in our open access journal.
Benefit from fast review, global visibility, and exclusive APC discounts.